Skip to content

EBITDA at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$20.4M+34.4%
Baxter International logo
Baxter InternationalBAX
Stryker logo
StrykerSYK
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

$2.8Mebit+
$1.6MDepreciation Depletion & Amortization
=-$1.23M

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's EBITDA?
Axogen (AXGN) reported EBITDA of -$1.23M in Q1 2026.
How has Axogen's EBITDA changed year-over-year?
Axogen's EBITDA decreased by 1932.8% year-over-year, from $67K to -$1.23M.
What is the long-term trend for Axogen's EBITDA?
Over 3 years (2021 to 2025), Axogen's EBITDA has grown at a -62.6% compound annual growth rate (CAGR), from -$22.67M to -$1.19M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.